Skip to main content

Devazepide

Tocris Bioscience a Bio-Techne Brand

CCK1 Receptor Antagonists Small Molecule
Catalog #
Availability
Size / Price
Qty
Loading...
2304/50
2304/10
15% Off Limited-time Savings on Your Reagents, Assays and Kits
Now through September 27th, you can save 15% on Bio-Techne reagents, assays, and kits (including Novus, Tocris and R&D Systems). Use promotion code SAVE15 at checkout on orders over $1,000. See terms and conditions for offer details.
Loading...
A Reputation of Quality: The Bio-Techne Brand Story

Key Product Details

Description: Selective, orally active CCK1 receptor antagonist
Alternative Names: L-364,718, MK 329
Chemical Name: N-[(3S)-2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-1H-indole-2-carboxamide
Purity: ≥99% (HPLC)
Molecular Weight: 408.46

Complete Your Research

Complete Your Experiment

Citations for Devazepide (9)

Showing  1 - 9 of 9 citations Showing All
Search Title:

Citations are publications that use Bio-Techne products. Selected citations for Devazepide include:

There are no citations that match your criteria.

Showing  1 - 9 of 9 citations Showing All

Customer Reviews for Devazepide (1)

5 out of 5
1 customer rating
5 stars
100%
4 stars
0%
3 stars
0%
2 stars
0%
1 star
0%

Customer Images


Showing  1 - 1 of 1 review Showing All
Filter By:
  • Works for block CCKA receptor.
    Name: Donovan Argueta
    Species: Mouse
    Assay Type: In Vivo
    Cell Line/Tissue: CCK-eGFP-positive cells
    We used low-fat chow fed mice and that is blocked by co-administration with the CCKA receptor antagonist by devazepide treatment.0.1 mg per kg for devazepide treatment
    Devazepide was dissolved in vehicle consisting of 7.5% DMSO, 7.5% Tween80, and 85% sterile saline, and warmed in a water bath to ensure solubility.
    Devazepide Serum 2304

There are no reviews that match your criteria.

Showing  1 - 1 of 1 review Showing All

Product Documents for Devazepide

Certificate of Analysis

To download a Certificate of Analysis, please select a batch below.